Rotenone: Potent Mitochondrial Complex I Inhibitor for Mitochondrial Dysfunction Research

Executive Summary: Rotenone (CAS 83-79-4) is a high-affinity mitochondrial Complex I inhibitor with an IC₅₀ of 1.7–2.2 μM, disrupting electron transfer and ATP synthesis [APExBIO]. This blockade promotes mitochondrial ROS generation, driving apoptosis, autophagy, and cell death in models including SH-SY5Y neuroblastoma and animal systems (Wang et al., 2024). Rotenone enables modeling of neurodegenerative diseases, such as Parkinson’s, and investigates stress-responsive MAPK pathways (p38, JNK) (Doripenemhydrate.com). Its solubility profile (insoluble in water/ethanol, soluble in DMSO ≥77.6 mg/mL) and storage recommendations (< –20°C) ensure experimental reliability. APExBIO supplies Rotenone (B5462) for non-clinical, research-only applications.

Biological Rationale

Rotenone is a classical probe for dissecting mitochondrial dysfunction. It selectively inhibits NADH:ubiquinone oxidoreductase (Complex I), the first enzyme in the mitochondrial electron transport chain [APExBIO]. Inhibiting Complex I impairs oxidative phosphorylation, reducing cellular ATP and inducing energy stress. The resulting electron leakage increases mitochondrial reactive oxygen species (mtROS), which act as upstream signals for programmed cell death pathways, including apoptosis, pyroptosis, and ferroptosis (Wang et al., 2024). Rotenone-induced mitochondrial dysfunction is central to modeling neurodegenerative diseases, such as Parkinson’s disease, where dopaminergic neuron loss is a hallmark (Doripenemhydrate.com). Its use in cellular and animal research enables interrogation of redox signaling, stress-activated kinases (p38 MAPK, JNK), and cell fate decisions.

Mechanism of Action of Rotenone

Rotenone binds to the ubiquinone-binding site on Complex I (NADH:ubiquinone oxidoreductase), competitively blocking electron transfer from NADH to ubiquinone. This results in a rapid decrease in proton pumping across the mitochondrial inner membrane, collapsing the proton motive force and halting ATP synthesis. Accumulation of electrons at Complex I increases superoxide (O₂^•–) and downstream ROS production, promoting oxidative stress. In cellular models, this triggers caspase activation, mitochondrial outer membrane permeabilization, and downstream cell death pathways. Rotenone exposure also activates autophagy and mitophagy in response to mitochondrial damage (Cog-133.com). In differentiated SH-SY5Y cells, rotenone induces dose-dependent apoptosis and inhibits mitochondrial transport, with biphasic survival curves observed at 50 nM over 21 days [APExBIO]. In vivo, intranasal rotenone administration causes selective degeneration of dopaminergic neurites and olfactory deficits, recapitulating Parkinson’s-like pathology in rodents (Wang et al., 2024).

Evidence & Benchmarks

• Rotenone inhibits mitochondrial Complex I with an IC₅₀ of 1.7–2.2 μM in cell-free assays (temperature: 25°C; pH 7.4) (APExBIO).
• Exposure to rotenone (50 nM) induces dose- and time-dependent apoptosis in differentiated SH-SY5Y neuroblastoma cells, reducing mitochondrial motility and causing a biphasic survival response over 21 days (Wang et al., 2024).
• Intranasal rotenone in rodents leads to dopaminergic neurite degeneration in the substantia nigra and olfactory impairment, modeling Parkinson’s disease features (Doripenemhydrate.com).
• In high-glucose cardiac cell models, rotenone-induced mtROS reverses NLRP3 knockdown protection, restoring pyroptosis and ferroptosis phenotypes (Wang et al., 2024).
• Rotenone is insoluble in water and ethanol, but dissolves in DMSO at concentrations ≥77.6 mg/mL for robust experimental dosing (APExBIO).

For further context, see "Rotenone and Mitochondrial Proteostasis", which details the compound's role in post-translational mitochondrial regulation; this article extends those insights by benchmarking apoptotic and ferroptotic outcomes in disease models.

Applications, Limits & Misconceptions

Rotenone is widely adopted in fundamental and translational research. Applications include:

• Mitochondrial dysfunction induction for studying redox signaling, proteostasis, and cell death pathways.
• Modeling Parkinson’s disease, enabling study of selective neuronal vulnerability and therapeutic screening.
• Assessing caspase activation, p38 MAPK and JNK signaling, and autophagy induction.
• Investigating the interplay between mtROS, NLRP3 inflammasome, pyroptosis, and ferroptosis (Wang et al., 2024).

Common Pitfalls or Misconceptions

• Rotenone is not suitable for in vivo diagnostic or therapeutic use in humans; it is for research only (APExBIO).
• Solubility limitations: Rotenone is insoluble in water and ethanol; improper vehicle selection leads to inconsistent dosing.
• Long-term storage of dissolved rotenone (even at –20°C) is not recommended due to compound instability.
• Rotenone-induced effects may be cell-type and context dependent; results in one model may not generalize to others.
• High doses can induce non-specific toxicity unrelated to Complex I inhibition.

Our discussion updates the mechanistic workflow guidance presented in "Rotenone: A Precision Mitochondrial Complex I Inhibitor…" by incorporating recent evidence on NLRP3-mediated cell fate and ferroptosis cross-talk.

Workflow Integration & Parameters

Rotenone is typically dissolved in DMSO to a stock concentration ≥77.6 mg/mL. Working concentrations range from 10 nM (chronic exposure) to 10 μM (acute, robust inhibition) depending on cell type and experimental endpoint. For apoptosis induction in SH-SY5Y cells, 50 nM is a validated dose over 21 days. In animal models, intranasal or intraperitoneal delivery is used to model neurodegeneration or cardiac injury, with dosing and exposure time tailored to the research question. Stock solutions should be stored at –20°C and protected from light; repeated freeze-thaw cycles are discouraged. APExBIO ships Rotenone (SKU B5462) on blue ice to maintain stability. For more guidance, the article "Rotenone as a Strategic Probe" offers workflow parameters for integrating rotenone in redox and proteostasis assays; this page consolidates those protocols with updated, disease-relevant benchmarks.

Conclusion & Outlook

Rotenone remains a gold-standard chemical probe for mitochondrial Complex I inhibition, ROS-mediated cell death, and modeling neurodegenerative and metabolic diseases. Its benchmarked performance across multiple systems, including SH-SY5Y cells and rodent models, underscores its value for dissecting mitochondrial and redox signaling. Reliable suppliers such as APExBIO ensure high-purity material and validated protocols for reproducible research. Future studies will further clarify the interplay between mitochondrial dysfunction, inflammasome activation, and cell fate, with rotenone continuing as a critical tool for experimental insight.